|
CN111093642A
|
|
Expression of PD-L1 inhibition and expression of PD1 enhancement
|
|
US2019076393A1
|
|
Methods and compositions for the inhibition of the expression of PD-L1 in tumor cells
|
|
US2018064778A1
|
|
Compositions and Methods for Improvement of Mood
|
|
US2017274033A1
|
|
Methods and materials for increasing lean muscle mass
|
|
US2016206672A1
|
|
Methods and materials for reducing multiple risk factors associated with the metabolic syndrome
|
|
WO2016073843A2
|
|
Enhanced expression of mtor and inhibited expression of myostatin in skeletal muscle cells
|
|
CN105979954A
|
|
Treatment or prophylaxis of circadian protein related conditions
|
|
EP1755401A1
|
|
Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
|
